Literature DB >> 1191432

Creatine kinase release in acute myocardial infarction: correlation with clinical, electrocardiographic, and pathological findings.

D Mathey, W Bleifeld, H Buss, P Hanrath.   

Abstract

Creatine kinase (CK) release curves were analysed in 40 patients with acute myocardial infarction. Three groups could be identified. Group A (duration of CK release less than 30 hours) comprised 15 patients whose CK release was completed within 22.8 hours. In these patients chest pain was noted on the first hospital day and necropsy in three showed a homogeneous myocardial infarction. Group B (duration of CK release greater then 30 hours) comprised 16 patients who had a significantly longer CK release time of 42.2 hours (P less than or equal to 0.05). Their chest pain persisted for two to three days and pathological examination in five patients showed a heterogeneous composition of the infarcted myocardium. Group C comprised nine patients who had a second rise of serum CK. This was always associated with chest pain. It reflected an extension of the infarct which accounted on average for 24 per cent of the size of the final infarct. We concluded that a CK release of short duration indicated infarction without extension, CK release of longer duration indicated a gradual extension of infarction, and a repeated CK release resulted from a sudden extension of an infarct. According to these criteria an extension of the infarct occurred in 62 per cent of our patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1191432      PMCID: PMC482934          DOI: 10.1136/hrt.37.11.1161

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  6 in total

1.  Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity.

Authors:  M M NACHLAS; T K SHNITKA
Journal:  Am J Pathol       Date:  1963-04       Impact factor: 4.307

2.  [Serial studies on creatine phosphokinase for intravital determination of the extent of the infarct].

Authors:  W Bleifeld; D Mathey; P Hanrath; H Buss; S Effert
Journal:  Verh Dtsch Ges Kreislaufforsch       Date:  1974

3.  Editorial: Assessing myocardial damage in acute infarcts.

Authors:  P R Maroko
Journal:  N Engl J Med       Date:  1974-01-17       Impact factor: 91.245

4.  Estimation of infarct size in man and its relation to prognosis.

Authors:  B E Sobel; G F Bresnahan; W E Shell; R D Yoder
Journal:  Circulation       Date:  1972-10       Impact factor: 29.690

5.  Depressed myocardial creatine phosphokinase activity following experimental myocardial infarction in rabbit.

Authors:  J K Kjekshus; B E Sobel
Journal:  Circ Res       Date:  1970-09       Impact factor: 17.367

6.  Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity.

Authors:  W E Shell; J K Kjekshus; B E Sobel
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

  6 in total
  13 in total

Review 1.  According to MIAMI and ISIS-I trials, can a general recommendation be given for beta blockers in acute myocardial infarction?

Authors:  J K Kjekshus
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

Review 2.  Creatine phosphokinase-MB (CPK-MB) and the diagnosis of myocardial infarction.

Authors:  P M Guzy
Journal:  West J Med       Date:  1977-12

3.  Correlation of ejection fraction and infarct size estimated from the total CK released in patients with acute myocardial infarction.

Authors:  M Hori; M Inoue; S Fukui; T Shimazu; M Mishima; N Ohgitani; T Minamino; H Abe
Journal:  Br Heart J       Date:  1979-04

4.  Kinetics of serum creatine kinase and creatine kinase-MB after intracoronary thrombolysis.

Authors:  F M Bartelsen; W Rehpenning; K Harm; M Runge; D G Mathey
Journal:  Klin Wochenschr       Date:  1985-06-03

5.  Evaluation of evolution of myocardial infarction by serial determinations of serum creatine kinase activity.

Authors:  M Inoue; M Hori; S Fukui; H Abe; T Minamino
Journal:  Br Heart J       Date:  1977-05

6.  Myocardial infarct extension. Identification of subgroups by the pattern of the serum CKMB level.

Authors:  M A Díaz Castellanos; J Latour Pérez; M T López Ortiz; J S Giner Boix; J A Rueda Cuenca
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

7.  The measurement and control of myocardial infarct size.

Authors:  M C Apps; J Tinker
Journal:  Intensive Care Med       Date:  1978-01       Impact factor: 17.440

8.  Excretion of myoglobin in urine after actue myocardial infarction.

Authors:  T G Donald; M J Cloonan; C Neale; D E Wilcken
Journal:  Br Heart J       Date:  1977-01

9.  Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol.

Authors:  J H Jürgensen; J Frederiksen; D A Hansen; O Pedersen-Bjergaard
Journal:  Br Heart J       Date:  1981-05

10.  Infarct size estimation from serial CK MB determinations: peak activity and predictability.

Authors:  J W Fiolet; H F ter Welle; F J van Capelle; K I Lie
Journal:  Br Heart J       Date:  1983-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.